These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 34782158
1. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016. Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Vaccine; 2021 Nov 26; 39(48):7101-7107. PubMed ID: 34782158 [Abstract] [Full Text] [Related]
2. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting. Duri K, Munjoma PT, Mataramvura H, Mazhandu AJ, Chandiwana P, Marere T, Gumbo FZ, Mazengera LR. BMC Infect Dis; 2023 Oct 27; 23(1):736. PubMed ID: 37891471 [Abstract] [Full Text] [Related]
3. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo. Ekouevi DK, Larrouy L, Gbeasor-Komlanvi FA, Mackiewicz V, Tchankoni MK, Bitty-Anderson AM, Gnatou GY, Sadio A, Salou M, Dagnra CA, Descamps D, Coffie PA. BMC Infect Dis; 2020 Nov 12; 20(1):839. PubMed ID: 33183254 [Abstract] [Full Text] [Related]
5. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Wang F, Zhang G, Zheng H, Miao N, Shen L, Wang F, Dong P, Du F, Chen C, Zhang X, Cui F. Vaccine; 2017 Jul 24; 35(33):4229-4235. PubMed ID: 28651839 [Abstract] [Full Text] [Related]
6. Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014. Abara WE, Cha S, Malik T, DeSimone MS, Schillie S, Collier M, Schumann B, Klemme M, Kamb M. J Pediatric Infect Dis Soc; 2018 Dec 03; 7(4):290-295. PubMed ID: 28992071 [Abstract] [Full Text] [Related]
7. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers. Zamir C, Dagan R, Zamir D, Rishpon S, Fraser D, Rimon N, Ben Porath E. Pediatr Infect Dis J; 1999 Mar 03; 18(3):262-6. PubMed ID: 10093949 [Abstract] [Full Text] [Related]
8. Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-Vaccination Serologic Testing. Su WJ, Chen HL, Chen SF, Liu YL, Wang TA, Ho YC, Chang MH. Clin Infect Dis; 2024 Sep 26; 79(3):690-700. PubMed ID: 38562001 [Abstract] [Full Text] [Related]
10. Hepatitis B vaccination in children: the Taiwan experience. Ni YH, Chen DS. Pathol Biol (Paris); 2010 Aug 26; 58(4):296-300. PubMed ID: 20116181 [Abstract] [Full Text] [Related]
11. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. Hu Y, Zhang S, Luo C, Liu Q, Zhou YH. BMC Infect Dis; 2012 Sep 17; 12():221. PubMed ID: 22984924 [Abstract] [Full Text] [Related]
12. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study. Shimakawa Y, Veillon P, Birguel J, Pivert A, Sauvage V, Guillou-Guillemette HL, Roger S, Njouom R, Ducancelle A, Amta P, Huraux JM, Adoukara JP, Lunel-Fabiani F. Lancet Glob Health; 2022 Apr 17; 10(4):e521-e529. PubMed ID: 35183302 [Abstract] [Full Text] [Related]
13. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: a major challenge to eliminate hepatitis B infection in Cambodia. E B, Ko K, Kim R, Nagashima S, Ouoba S, Hussain MRA, Sato T, Chuon C, Abe K, Sugiyama A, Takahashi K, Akita T, Tung R, Ork V, Hossain MS, Saphonn V, Tanaka J. BMC Infect Dis; 2023 Apr 26; 23(1):261. PubMed ID: 37101167 [Abstract] [Full Text] [Related]
14. A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap. Qin W, Wang Y, Zhang X, Pan F, Cheng K, Sui H, Xie S. Hum Vaccin Immunother; 2022 Dec 30; 18(7):2155390. PubMed ID: 36514905 [Abstract] [Full Text] [Related]
15. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia. Argaw B, Mihret A, Aseffa A, Tarekegne A, Hussen S, Wachamo D, Shimelis T, Howe R. BMC Infect Dis; 2020 Jul 22; 20(1):528. PubMed ID: 32698884 [Abstract] [Full Text] [Related]
18. Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country. Copiz GI, Ibañez C, Piñera C, Cordova L, Payá E, Leal P, Villena R. Matern Child Health J; 2024 Apr 22; 28(4):767-774. PubMed ID: 38358537 [Abstract] [Full Text] [Related]
19. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L. Vaccine; 2014 Oct 21; 32(46):6091-7. PubMed ID: 25240752 [Abstract] [Full Text] [Related]